Inhibition of Chk1 Kinase Sensitizes Leukemia and Lymphoma Cell Lines with TP53 Mutations to Chemotherapy

被引：0

作者：

Zemanova, Jana ^{[1
]}

Sebejova, Ludmila ^{[1
]}

Hylse, Ondrej ^{[2
]}

Paruch, Kamil ^{[2
]}

Pavlova, Sarka ^{[1
]}

Mayer, Jiri ^{[3
,4
]}

Pospisilova, Sarka ^{[1
]}

Trbusek, Martin ^{[1
]}

机构：

[1] Masaryk Univ, Cent European Inst Technol CEITEC, Brno, Czech Republic

[2] St Annes Univ Hosp, Ctr Biomol & Cellular Engn, Int Clin Res Ctr, Brno, Czech Republic

[3] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic

[4] Masaryk Univ, Fac Med, Brno, Czech Republic

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

10.1182/blood.V120.21.2460.2460

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2460

引用

页数：2

共 50 条

[41] Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Involving Cerebrospinal Fluid (CSF) Shows Pathogenic TP53 Mutations
Shestakova, Anna
Haghighu, Nahideh
Souccar, Sami
Zhao, Xiaohui
Chan, Jefferson
Rezk, Sherif
LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1383 - 1384
[42] Inhibition of CHK1 sensitizes Ewing sarcoma cells to CDK1-dependent cell death in S-phase
Gordon, David
Goss, Kelli
Koppenhafer, Stacia
CANCER RESEARCH, 2019, 79 (13)
[43] A specific linkage between the incidence of TP53 mutations and type of chromosomal translocations in B-precursor acute lymphoblastic leukemia cell lines
Inukai, Takeshi
Zhang, Xiuru
Kameyama, Takeshi
Suzuki, Yukiko
Yoshikawa, Kazuhito
Kuroda, Itaru
Nemoto, Atsushi
Akahane, Koshi
Sato, Hiroki
Goi, Kumiko
Nakamoto, Kazunori
Hamada, Jun-ichi
Tada, Mitsuhiro
Moriuchi, Tetsuya
Sugita, Kanji
AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (07) : 535 - 537
[44] Frequent RUNX1 and TP53 Mutations in Secondary Acute Myeloid Leukemia with Mixed Phenotype
Galera, Pallavi
Baik, Jeeyeon
Famulare, Christopher
Sigler, Allison
Zhang, Yanming
Arcila, Maria
Dogan, Ahmet
Tallman, Martin
Levine, Ross
Glass, Jacob
Roshal, Mikhail
Xiao, Wenbin
MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1293 - 1294
[45] Frequent RUNX1 and TP53 Mutations in Secondary Acute Myeloid Leukemia with Mixed Phenotype
Galera, Pallavi
Baik, Jeeyeon
Famulare, Christopher
Sigler, Allison
Zhang, Yanming
Arcila, Maria
Dogan, Ahmet
Tallman, Martin
Levine, Ross
Glass, Jacob
Roshal, Mikhail
Xiao, Wenbin
LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1293 - 1294
[46] BUB1 Inhibition Sensitizes TNBC Cell Lines to Chemotherapy and Radiotherapy
Sriramulu, Sushmitha
Thoidingjam, Shivani
Siddiqui, Farzan
Brown, Stephen L.
Movsas, Benjamin
Walker, Eleanor
Nyati, Shyam
BIOMOLECULES, 2024, 14 (06)
[47] HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1
Busch, Chia-Jung
Kriegs, Malte
Laban, Simon
Tribius, Silke
Knecht, Rainald
Petersen, Cordula
Dikomey, Ekkehard
Rieckmann, Thorsten
RADIOTHERAPY AND ONCOLOGY, 2013, 108 (03) : 495 - 499
[48] TP53 Mutations are Common in Mantle Cell Lymphoma, Including the Indolent Leukemic Non-Nodal Variant
Sakhdari, Ali
Patel, Keyur
Ok, Chi Young
Kanagal-Shamanna, Rashmi
Yin, C. Cameron
Zuo, Zhuang
Hu, Shimin
Routbort, Mark
Luthra, Rajyalakshmi
Medeiros, L. Jeffrey
Khoury, Joseph
Loghavi, Sanam
LABORATORY INVESTIGATION, 2018, 98 : 549 - 549
[49] TP53 Mutations are Common in Mantle Cell Lymphoma, Including the Indolent Leukemic Non-Nodal Variant
Sakhdari, Ali
Patel, Keyur
Ok, Chi Young
Kanagal-Shamanna, Rashmi
Yin, C. Cameron
Zuo, Zhuang
Hu, Shimin
Routbort, Mark
Luthra, Rajyalakshmi
Medeiros, L. Jeffrey
Khoury, Joseph
Loghavi, Sanam
MODERN PATHOLOGY, 2018, 31 : 549 - 549
[50] Frequency, Spectrum, and Functional Significance of TP53 Mutations in Patients with Diffuse Large B-Cell Lymphoma
Voropaeva, E. N.
Pospelova, T. I.
Voevoda, M. I.
Maksimov, V. N.
MOLECULAR BIOLOGY, 2017, 51 (01) : 53 - 60

← 1 2 3 4 5 →